Skip to main content

Table 4 The proportion of cases and controls with evidence of infection with HPV, stratified by HIV serostatus

From: Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: A case-control study in Uganda

  All HPV1 Genital HPV2 Cutaneous-HPV3
  Case4 Control Odds Ratio (95% CI) Case4 Control Odds Ratio (95% CI) Case4 Control Odds Ratio (95% CI)
HIV seronegative 45% (10/22) 32% (6/19) 1.8 (0.4–7.9) 36% (8/22) 32% (6/19) 1.2 (0.3–5.5) 27% (6/22) 0% (0/19) ∞ (1.8–∞)
HIV seropositive 48% (25/52) 50% (5/10) 0.9 (0.2–4.3) 40% (21/52) 50% (5/10) 0.8 (0.2–3.8) 21% (11/52) 10% (1/10) 2.2 (0.2–52)
TOTAL 47% (38/81) 38% (11/29) 1.5 (0.6–3.8) 38% (31/81) 38% (11/29) 1.0 (0.4–2.7) 22% (18/81) 3% (1/29) 8.0 (1.0–169)
  1. 1. More than one HPV type was identified in tissue from 19 cases and four controls
  2. 2. Genital HPV types investigated: 6, 11, 16, 18, 31, 33–35, 39, 40, 42–45, 51–54, 56, 58, 59, 66, 68, 70, 74. Genital HPV types identified: 6, 11, 16, 18, 31, 33, 35, 44, 51, 52, 66, plus two unclassifiable; high risk genital types were identified in 13 cases (types 16 [eight people], 51 and 66 [in one person] 18, 35, 51 and 52 [one person each]) and in three controls (types 31 and 33 [two people]); HPV 11 was most frequently detected (22 cases and 10 controls)
  3. 3. Cutaneous HPV types investigated: 5, 8, 9, 12, 14, 15, 17, 19–25, 36–38, 47, 49, 75, 76, 80, 92, 93, 96. Cutaneous HPV types identified: 5, 8, 14, 17, 19, 23, 36, 37, 80, plus 9 unclassifiable; HPV 14 was identified in three cases and types 8, 17 and 23 were found in two people each
  4. 4. Among cases, 7 had unknown HIV serostatus